Showing results (371-380 of 454) with videos related to
Sort By:
Pageof 46
Cancer Research|December 1, 1995
Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigenM Juweid, R M Sharkey, T Behr, et al.Cancer|July 1, 1996
Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2M Juweid, R M Sharkey, T M Behr, et al.Cancer|September 1, 1979
Carcinoembryonic antigen in carcinoma of the uterine cervix. 2. Tissue localization and correlation with plasma antigen concentrationJ R van Nagell, E S Donaldson, E C Gay, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Rat adjuvant arthritis: imaging with technetium-99m-anti-CD4 Fab' fragmentsR W Kinne, W Becker, T Koscheck, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1996
Reduction of renal uptake of monoclonal antibody fragments by amino acid infusionT M Behr, W S Becker, R M Sharkey, et al.Cancer|December 24, 1997
Generation of a high-producing clone of a humanized anti-B-cell lymphoma monoclonal antibody (hLL2)M J Losman, H J Hansen, H Dworak, et al.Cancer|February 1, 1994
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomasR M Sharkey, D M Goldenberg, R Vagg, et al.Cancer|March 15, 1993
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14R M Sharkey, D M Goldenberg, S Murthy, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emittersS V Govindan, D M Goldenberg, S E Elsamra, et al.Clinical Immunology (Orlando, Fla.)|April 25, 2001
Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosusM Honda, E Mengesha, S Albano, et al.Pageof 46